Contents

Current Pharmaceutical Biotechnology, Volume 13 - Number 10

Editorial

Editorial: [Hot Topic: Drug Development in Dermatology: New Targets for Old Diseases?]

, 13(10): 1859 - 1860

Riccardo G. Borroni


DOI: 10.2174/138920112802273317




Psoriasis, from Pathogenesis to Therapeutic Strategies: IL-21 as a Novel Potential Therapeutic Target

, 13(10): 1861 - 1867

Elisabetta Botti, Giulia Spallone, Roberta Caruso, Giovanni Monteleone, Sergio Chimenti and Antonio Costanzo


DOI: 10.2174/138920112802273281




Gene Therapy of Skin Adhesion Disorders (Mini Review)

, 13(10): 1868 - 1876

Alessia Cavazza and Fulvio Mavilio


DOI: 10.2174/138920112802273119




Apoptotic Pathways in the Pathogenesis of Pemphigus: Targets for New Therapies

, 13(10): 1877 - 1881

Roberta Lotti, Alessandra Marconi and Carlo Pincelli


DOI: 10.2174/138920112802273236




Role of Defensins and Cathelicidin LL37 in Auto-Immune and Auto- Inflammatory Diseases

, 13(10): 1882 - 1897

Loredana Frasca and Roberto Lande


DOI: 10.2174/138920112802273155




New Pharmaceutical Concepts for Sebaceous Gland Diseases: Implementing Today’s Pre-Clinical Data into Tomorrow’s Daily Clinical Practice

, 13(10): 1898 - 1913

Vasiliki A. Zampeli, Evgenia Makrantonaki, Thrasivoulos Tzellos and Christos C. Zouboulis


DOI: 10.2174/138920112802273173




Editorial

Editorial: [Hot Topic: Antidotes and Rescue Therapies]

, 13(10): 1914 - 1916

Richard Y. Wang and Ziad N. Kazzi


DOI: 10.2174/138920112802273164




Acetylcysteine Therapy for Acetaminophen Poisoning

, 13(10): 1917 - 1923

Kennon Heard and Jody Green


DOI: 10.2174/138920112802273146




Antidote Control of Aptamer Therapeutics: The Road to a Safer Class of Drug Agents

, 13(10): 1924 - 1934

K. M. Bompiani, R. S. Woodruff, R. C. Becker, S. M. Nimjee and B. A. Sullenger


DOI: 10.2174/138920112802273137




Black Widow Spider (Latrodectus mactans) Antivenom in Clinical Practice

, 13(10): 1935 - 1939

Andrew A. Monte


DOI: 10.2174/138920112802273335




Antidotes for Acute Cyanide Poisoning

, 13(10): 1940 - 1948

Stephen W. Borron and Frederic J. Baud


DOI: 10.2174/138920112802273182




Dexrazoxane for the Prevention of Cardiac Toxicity and Treatment of Extravasation Injury from the Anthracycline Antibiotics

, 13(10): 1949 - 1956

James H. Doroshow


DOI: 10.2174/138920112802273245




Calcium and Zinc DTPA Administration for Internal Contamination with Plutonium-238 and Americium-241

, 13(10): 1957 - 1963

Ziad N. Kazzi, Alexander Heyl and Johann Ruprecht


DOI: 10.2174/138920112802273308




Legalon® SIL: The Antidote of Choice in Patients with Acute Hepatotoxicity from Amatoxin Poisoning

, 13(10): 1964 - 1970

Ulrich Mengs, Ralf - Torsten Pohl and Todd Mitchell


DOI: 10.2174/138920112802273353




Reactive Skin Decontamination Lotion (RSDL) for the Decontamination of Chemical Warfare Agent (CWA) Dermal Exposure

, 13(10): 1971 - 1979

M. D. Schwartz, C. G. Hurst, M. A. Kirk, S. J.D. Reedy and E. H. Braue


DOI: 10.2174/138920112802273191




Antivenoms for Snakebite: Design, Function, and Controversies

, 13(10): 1980 - 1986

Eric J. Lavonas


DOI: 10.2174/138920112802273227




Editorial

Editorial: [Hot Topic: Primary Sjogren’s Syndrome Research and Therapy: Has a New Dawn Arrived?]

, 13(10): 1987 - 1988

Wan-Fai Ng


DOI: 10.2174/138920112802273272




Ectopic Lymphoid Neogenesis and Lymphoid Chemokines in Sjogren’s Syndrome: At the Interplay between Chronic Inflammation, Autoimmunity and Lymphomagenesis

, 13(10): 1989 - 1996

Michele Bombardieri and Costantino Pitzalis


DOI: 10.2174/138920112802273209




Biologic Therapies in Primary Sjögren's Syndrome

, 13(10): 1997 - 2008

S. J. Bowman


DOI: 10.2174/138920112802273263




Local Activation and Systemic Dysregulation of T Lymphocytes in Sjögren’s Syndrome

, 13(10): 2009 - 2021

Robert Busch, Andreas V. Hadjinicolaou and Frances C. Hall


DOI: 10.2174/138920112802273092




Primary Sjogren’s Syndrome: Time for Prospective Cohorts

, 13(10): 2022 - 2025

Jacques-Eric Gottenberg and Xavier Mariette


DOI: 10.2174/138920112802273128




Current and Future Challenges in Primary Sjogren’s Syndrome

, 13(10): 2026 - 2045

Arjan Vissink, Hendrika Bootsma, Fred KL Spijkervet, Shen Hu, David T Wong and Cees GM Kallenberg


DOI: 10.2174/138920112802273254




Epigenetics and Sjogren’s Syndrome

, 13(10): 2046 - 2053

Christelle Le Dantec, Marie-Michele Varin, Wesley H Brooks, Jacques-Olivier Pers, Pierre Youinou and Yves Renaudineau


DOI: 10.2174/138920112802273326




Primary Sjogren’s Syndrome and the Type I Interferon System

, 13(10): 2054 - 2062

Gunnel Nordmark, Maija-Leena Eloranta and Lars Ronnblom


DOI: 10.2174/138920112802273290




Autoantibodies and Sjogren’s Syndrome: A Physiologist’s Perspective

, 13(10): 2063 - 2070

Peter M. Smith and Luke J. Dawson


DOI: 10.2174/138920112802273218




B-Lymphocytes Govern the Pathogenesis of Sjogren's Syndrome

, 13(10): 2071 - 2077

Pierre Youinou, Alain Saraux and Jacques-Olivier Pers


DOI: 10.2174/138920112802273100




Principles and Applications of Selective Biophysical Methods for Characterization and Comparability Assessment of a Monoclonal Antibody

, 13(10): 2078 - 2101

Haripada Maity, Yin Lai, Arvind Srivastava and Joel Goldstein


DOI: 10.2174/138920112802273344




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science